CompletedPhase 2NCT01162967
Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
Studying American trypanosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Principal Investigator
- Molina Israel, MDInfectious Disease Department Vall d'Hebron Hospital
- Intervention
- Benznidazole(drug)
- Enrollment
- 78 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2013
Study locations (3)
- International Health Unit Metropolitana Nord, Santa Coloma, Barcelona, Spain
- Infectious Disease Department Vall d'Hebron Hospital, Barcelona, Spain
- International Health Unit Drassanes, Barcelona, Spain
Collaborators
Hospital Vall d'Hebron · Tropical Medicine and International Health Unit Drassanes. Barcelona · International Health Unit Metropolitana Nord. Santa Coloma.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01162967 on ClinicalTrials.govOther trials for American trypanosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06632600A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.Novartis Pharmaceuticals
- ENROLLING BY INVITATIONNCT07033325University-Based Chagas Testing in Salta Province, ArgentinaMundo Sano Foundation
- RECRUITINGPHASE3NCT04897516Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseLaboratorio Elea Phoenix S.A.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04984265SBRT in Chagas Disease Ventricular TachycardiaUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT04024163Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas DiseaseInsud Pharma